[Responsibilities of clinical research in the development of new drugs].
D000818:Animals; D001317:Austria; D004285:Dogs; D004345:Drug Industry; D004358:Drug Therapy; D004335:Drug and Narcotic Control; D006801:Humans; D008660:Metabolism / Q000187:drug effects; D051379:Mice; D010600:Pharmacology; D010919:Placebos; D012106:Research; D013421:Sulfamethoxypyridazine / Q000378:metabolism; D013426:Sulfaphenazole / Q000378:metabolism; D013443:Sulfisomidine / Q000378:metabolism; D013444:Sulfisoxazole / Q000378:metabolism; D014309:Tripelennamine / Q000494:pharmacology
D010919:Placebos; D013426:Sulfaphenazole; D014309:Tripelennamine; D013444:Sulfisoxazole; D013421:Sulfamethoxypyridazine; D013443:Sulfisomidine
Aufgaben der klinischen Forchung bei der Entwicklung neuer Heilmittel.